A detailed history of High Mark Wealth Management LLC transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, High Mark Wealth Management LLC holds 230 shares of BLUE stock, worth $89. This represents 0.0% of its overall portfolio holdings.

Number of Shares
230
Previous 230 -0.0%
Holding current value
$89
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 22, 2021

BUY
$16.59 - $33.89 $1,907 - $3,897
115 Added 100.0%
230 $7,000
Q1 2020

Apr 30, 2020

BUY
$26.16 - $63.5 $3,008 - $7,302
115 New
115 $3,000

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $30.1M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track High Mark Wealth Management LLC Portfolio

Follow High Mark Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Mark Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Mark Wealth Management LLC with notifications on news.